Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected Patients
Goal. To study the effect of combination antiviral therapy with tenofovir and emtricitabine or lamivudine with and without prior monotherapy with lamivudine. Study. We reviewed charts of 31 HIV-/HBV-coinfected patients. Twelve 3TC-naïve patients initially received tenofovir plus emtricitabine. Nine...
Main Authors: | Engell, Christian A., Pham, Vinh Philip, Holzman, Robert S., Aberg, Judith A. |
---|---|
Format: | Online |
Language: | English |
Published: |
International Scholarly Research Network
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168392/ |
Similar Items
-
Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B–Coinfected Adults
by: Gallant, Joel, et al.
Published: (2016) -
Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir
by: Patil, Rashmee, et al.
Published: (2015) -
Triple-combination rilpivirine, emtricitabine, and tenofovir (Complera™/Eviplera™) in the treatment of HIV infection
by: Bernardini, Claudia, et al.
Published: (2013) -
Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection
by: Huang, Yu-Shan, et al.
Published: (2016) -
Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort
by: Pinnetti, Carmela, et al.
Published: (2014)